Latest News
Biostar Pharmaceuticals, Inc. Announces Its Quarte...
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017 XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, In...
  Shaanxi University
March 6th: Partnered with the Research Institute of Pharmaceuticals at Shaanxi University of Chinese Medicine to develop a new liver cancer drug. Current cases of cancer on a global scale has been increasing dramatically with China holding the larger percentage of the demographic. According to the World Health Organization (WHO), in 2012 on a global basis, there were 14 million new cancer cases and 8.2 million deaths; China accounted for 3.07 million of the new cases and 2.2 million of the deaths. In 2012, China accounted for approximately 50% of the worlds liver cancer cases.